Epstein Secrets

-30 January 2011 Michael J. Abbott Zein Abdalla Mustafa Abdel-Wadood Abdul Rahman Mohd Razali Khalid Abdulla-Janahi Hafsat Abiola-Costello Magid Abraham Reuben Abraham Phillip Abrary Issa Abdul Salem Abu Issa Mikhail A. Abyzov Aclan Mar Paul Achleitner Josef Ackermann Mohamed Adam Ken Adelman

cutive Officer Business Editor Secretary-General Chief Executive Officer Chief Executive Officer Managing Director, Legal and Risk Professor of Management Practice President, Merck Vaccines Director, Center for Public Leadership Artistic and General Director Managing Partner, Strategy and Business Developme

land, 26-30 January Michael J. Abbott Zein Abdalla Mustafa Abdel-Wadood Abdul Rahman Mohd Razali Khalid Abdulla-Janahi Hafsat Abiola-Costello Magid Abraham Reuben Abraham Phillip Abrary Issa Abdul Salam Abu Issa Mikhail A. Abyzov Aclan Acar Paul Achleitner Josef Ackermann Mohamed Adam Carol Adelm

Executive Officer Amdocs Management Ltd USA Pierre Gentin Managing Director, Legal and Risk Credit Suisse USA William W. George Professor of Management Practice Harvard Business School USA Julie Louise Gerberding President, Merck Vaccines Merck & Co. Inc. USA David R. Gergen Director, Center for Publi

land, 26-30 January Michael J. Abbott Zein Abdalla Mustafa Abdel-Wadood Abdul Rahman Mohd Razali Khalid Abdulla-Janahi Hafsat Abiola-Costello Magid Abraham Reuben Abraham Phillip Abrary Issa Abdul Salam Abu Issa Mikhail A. Abyzov Aclan Acar Paul Achleitner Josef Ackermann Mohamed Adam Carol Adelm

Executive Officer Amdocs Management Ltd USA Pierre Gentin Managing Director, Legal and Risk Credit Suisse USA William W. George Professor of Management Practice Harvard Business School USA Julie Louise Gerberding President, Merck Vaccines Merck & Co. Inc. USA David R. Gergen Director, Center for Publi